BTMD biote Corp.

NASDAQ
$1.04

biote Corp. (BTMD) is expected to report earnings on February 3, 2027, after the market close. The consensus earnings estimate is a loss of $0.03 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.0% since its last earnings release on November 4, 2026.

biote Beat Expectations, Reaffirms Revenue Guidance
Wednesday, November 4, 2026 · 4:11 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 3
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.03)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.04

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About biote Corp.

Biote is transforming healthy aging through innovative, personalized hormone optimization therapies delivered by Biote-certified medical providers.

Sector

Healthcare

Industry

Specialized Health Services

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.